Dr. Emma Rita Serrano, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1601 Mayview Rd, Bridgeville, PA 15017 Phone: 412-257-6682 |
Dr. Shashi B Marwah, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1601 Mayview Road, Mayview State Hospital, Bridgeville, PA 15017 Phone: 412-257-6668 |
Dr. Robert Taraszewski, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1601 Mayview Rd, Bridgeville, PA 15017 Phone: 412-257-6700 |
Dr. Bang H Lee, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1601 Mayview Rd, Bridgeville, PA 15017 Phone: 412-257-6369 |
Dr. Leticia Quinto Jariwala, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1601 Mayview Rd, Bridgeville, PA 15017 Phone: 412-257-6817 |
News Archive
Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of approximately $528,000, or $0.01 per share, for the quarter ended September 30, 2010, compared with a net loss applicable to common stock of approximately $3,243,000 or $0.06 per share, for the prior year quarter.
Consumer Watchdog and the Center for Media and Democracy today asked the Obama administration to investigate how the major for-profit health insurance companies are reducing their proportion of spending on health care in advance of health reform, even as premiums spike upward. In a letter to Health and Human Services chief Kathleen Sebelius, the groups compared insurers' actions to those of credit card companies, which spiked annual interest rates last year in advance of new federal regulations that would curb corporate abuses.
GNYHA Services, Inc. and Essensa, Inc., leading group purchasing organizations serving acute care, alternate care, and non-healthcare markets, have added MedSnap ID to their portfolio of technology offerings.
The antibody works against the gastric hormone ghrelin (pronounced "grell-in"), which has been linked to weight gain and fat storage through its metabolic actions. These findings point towards a potentially novel treatment for obesity that would interfere directly with the some of the biological mechanisms determining weight.
People who take statin drugs to lower their cholesterol appear to have developed a false sense of security that could lead to heart disease and other obesity-related illnesses.
› Verified 5 days ago